Guidance on Allocating and Targeting Pandemic Influenza Vaccine

Source: U.S. Department Of Health And Human Services and U.S. Department Of Homeland Security, 2008

Effective allocation of pandemic influenza vaccine will play a critical role in preventing influenza and reducing its effects on health and society when a pandemic arrives. The specific type of influenza that causes a pandemic will not be known until it occurs. Developing a new vaccine in response will take several months and pandemic vaccine may not be available when cases first occur in the United States. Moreover, once vaccine production begins, it will not be possible to make enough new vaccine to protect everyone in the early stages of a pandemic.

The U.S. Government is taking steps to minimize the need to make vaccine allocation decisions by supporting efforts to increase domestic influenza vaccine production capacity. Significant funding is being provided to develop new vaccine technologies that allow production of enough pandemic influenza vaccine for any person in the United States who wants to be vaccinated within six months of a pandemic declaration. Until this goal is met, Federal, State, local and tribal governments, communities, and the private sector will need guidance on who should be vaccinated earlier during the pandemic to best protect our people, communities, and country.
See also:
Vaccination plan puts health care workers first
Source: Maggie Fox, Reuters, July 23, 2008

Using Quality Improvement Methods To Improve Public Health Emergency Preparedness: PREPARE For Pandemic Influenza
(subscription required)
Source: Debra Lotstein, Michael Seid, Karen Ricci, Kristin Leuschner, Peter Margolis, Nicole Lurie, Health Affairs, Web Exclusives, July 15, 2008
abstract

Leave a Reply